Ningbo Menovo Pharmaceutical Co Ltd Class A 603538
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥11.52
- Day Range
- ¥11.77–12.67
- 52-Week Range
- ¥9.96–22.02
- Bid/Ask
- ¥12.67 / ¥0.00
- Market Cap
- ¥2.77 Bil
- Volume/Avg
- 10.5 Mil / 2.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 35.47
- Price/Sales
- 2.36
- Dividend Yield (Trailing)
- 0.16%
- Dividend Yield (Forward)
- 0.16%
- Total Yield
- 0.16%
Company Profile
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,353
- Website
- http://www.menovopharm.com
Comparables
Valuation
|
Metric
|
603538
|
600594
|
600216
|
|---|---|---|---|
Price/Earnings (Normalized) | 35.47 | — | 68.87 |
Price/Book Value | 1.31 | 1.11 | 1.67 |
Price/Sales | 2.36 | 1.20 | 1.98 |
Price/Cash Flow | — | 14.04 | 16.04 |
Price/Earnings
603538
600594
600216
Financial Strength
|
Metric
|
603538
|
600594
|
600216
|
|---|---|---|---|
Quick Ratio | 0.73 | 1.21 | 1.68 |
Current Ratio | 1.24 | 1.82 | 2.66 |
Interest Coverage | 0.70 | −3.36 | 15.43 |
Quick Ratio
603538
600594
600216
Profitability
|
Metric
|
603538
|
600594
|
600216
|
|---|---|---|---|
Return on Assets (Normalized) | 0.05% | −3.17% | 1.81% |
Return on Equity (Normalized) | 0.11% | −5.06% | 2.37% |
Return on Invested Capital (Normalized) | 0.48% | −3.17% | 2.20% |
Return on Assets
603538
600594
600216
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Rfbnlktz | Nmthv | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Chfqxttzn | Gvtxl | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Wntyshjms | Lrzh | $45.9 Bil | |||
| Viatris Inc
VTRS
| Mrwfzgc | Bfdm | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Xdxrmdhmh | Qbr | $13.2 Bil | |||
| Catalent Inc
CTLT
| Zqyswgdzp | Htbdcl | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Bbtngzpf | Qjspbmv | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Kqwfqpcsr | Hct | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Mbyjdnztf | Jmvjs | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Kkmqkjm | Vdj | $2.2 Bil |
United States